Shelf-stable nitrogenous organic acid compositions
AssigneeGlanbia Dairy Nutrition Limited
InventorsGaurav Parekh, Brent L. Petersen
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for making shelf-stable nitrogenous organic acid (e.g., creatine) ingredients for products such as nutritional bars, liquids, and/or powders.
Claims13
A method for making a shelf-stable encapsulated creatine monohydrate colloidal dispersion composition the method comprising the steps of combining starting materials comprising lecithin, water, at least one polysaccharide, and, optionally, calcium chloride to form a surfactant solution;
- admixing creatine monohydrate with the surfactant solution to form a dispersion;
- homogenizing the dispersion;
- and spray-drying the dispersion to produce the encapsulated creatine monohydrate colloidal dispersion composition;
- wherein the at least one polysaccharide comprises a non-pectin polysaccharide;
- wherein the at least one polysaccharide has a bound galacturonic acid value of at least about 8 g/100 g;
- wherein the method produces a creatine monohydrate encapsulation efficiency of about 95%;
- wherein the creatine monohydrate has a net concentration of 23.7-40.2 g/100 g as in dispersion;
- wherein the lecithin has a net concentration of 3.1-9.9 g/100 g as in dispersion;
- and wherein the at least one polysaccharide has a net concentration of 4.9-10.2 g/100 g as in dispersion.
A method for making a shelf-stable encapsulated creatine monohydrate colloidal dispersion composition, the method comprising the steps of combining lecithin, water, and at least one polysaccharide with a bound galacturonic acid value of less than about 8 g/100 g to form a surfactant solution;
- admixing nitrogenous organic acid creatine monohydrate with a particle size of less than 80 μm with the surfactant solution to form a dispersion;
- homogenizing the dispersion;
- and spray-drying the dispersion to produce the encapsulated nitrogenous organic acid creatine monohydrate colloidal dispersion composition;
- wherein the polysaccharide is selected from the group consisting of maltodextrin, alpha cyclodextrin, and combinations thereof;
- wherein the encapsulated creatine monohydrate colloidal dispersion composition has a chemical stability of about 67% after 12 months at a neutral pH;
- wherein the creatine monohydrate has a net concentration of 23.7-40.2 g/100 g as in dispersion;
- wherein the lecithin has a net concentration of 3.1-9.9 g/100 g as in dispersion;
- and wherein the at least one polysaccharide has a net concentration of 4.9-10.2 g/100 g as in dispersion.
A method for making a shelf-stable encapsulated creatine monohydrate colloidal dispersion composition, the method comprising the steps of combining soy lecithin, water, maltodextrin, and alpha cyclodextrin, to form a surfactant solution;
- admixing creatine monohydrate with the surfactant solution to form a dispersion;
- pasteurizing the dispersion;
- homogenizing the dispersion;
- and spray-drying the dispersion to produce the encapsulated creatine monohydrate colloidal dispersion composition;
- wherein the method produces a creatine monohydrate encapsulation efficiency of about 95%;
- wherein the creatine monohydrate has a net concentration of 23.7-40.2 g/100 g as in dispersion;
- wherein the lecithin has a net concentration of 3.1-9.9 g/100 g as in dispersion;
- and wherein the at least one polysaccharide has a net concentration of 4.9-10.2 g/100 g as in dispersion.
Dependencies are inferred from the claim text.